BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu Y, Mullin A, Stoita A. Clinical predictors for sessile serrated polyposis syndrome: A case control study. World J Gastrointest Endosc 2017; 9(9): 464-470 [PMID: 28979711 DOI: 10.4253/wjge.v9.i9.464]
URL: https://www.wjgnet.com/1948-5190/full/v9/i9/464.htm
Number Citing Articles
1
Emma Anthony, Jeanette C. Reece, Elasma Milanzi, Jihoon E. Joo, Sharelle Joseland, Mark Clendenning, Amanda Whelan, Susan Parry, Julie Arnold, Varnika Vijay, Nathan Atkinson, John L. Hopper, Aung K. Win, Mark A. Jenkins, Finlay A. Macrae, Ingrid M. Winship, Christophe Rosty, Daniel D. Buchanan. Body Mass Index, sex, non-steroidal anti-inflammatory drug medications, smoking and alcohol are differentially associated with World Health Organisation criteria and colorectal cancer risk in people with Serrated Polyposis Syndrome: an Australian case-control studyBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02557-7
2
Charles Muller, Akihiro Yamada, Sachie Ikegami, Haider Haider, Yuga Komaki, Fukiko Komaki, Dejan Micic, Atsushi Sakuraba. Risk of Colorectal Cancer in Serrated Polyposis Syndrome: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology 2022; 20(3): 622 doi: 10.1016/j.cgh.2021.05.057
3
Laxmi B. Chavali, Kun Hu, Anish Sheth, Nan Gao, Wei Xiong, Lanjing Zhang. Colorectal sessile serrated lesion with large size or synchronous neoplasm: a prospective studyEuropean Journal of Gastroenterology & Hepatology 2020; 32(2): 199 doi: 10.1097/MEG.0000000000001642